SCHEMBL9706902

SCHEMBL9706902

CCNC(=O)NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28293734 0.81 MMP1 (0.48)
SCHEMBL320068 0.81
SCHEMBL9706907 0.78
SCHEMBL17120970 0.75 MMP1 (0.43)
SCHEMBL10846295 0.74
SCHEMBL23173031 0.73 EPHX1 (0.52)
SCHEMBL3723886 0.73
SCHEMBL43908 0.73
SCHEMBL7749581 0.72
SCHEMBL31852 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0473509-A2 Method for preparation of zeolites based on silica and, possibly, oxides of tetravalent elements RHONE-POULENC CHIMIE (FR) 1992-03-04 EP disclosed
EP-0424187-A1 Process for the preparation of pillared clays and the pillared clays obtained from the process RHONE-POULENC CHIMIE (FR) 1991-04-24 EP disclosed
US-4618610-A Triazine derivatives, and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-21 US disclosed
EP-0123254-A1 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 EP disclosed